Nicholas Lowe | |
---|---|
Born | England | July 10, 1944
Education | University of Liverpool |
Occupation | Dermatologist |
Title | Clinical Professor of Dermatology |
Nicholas J Lowe (born 10 July 1944) is an English dermatologist who has published research into skin pharmacology, botulinum toxins, injectable filler and Lasers in cutaneous and cosmetic Surgery. [1]
He was president of the British Cosmetic Dermatology Group from 2013 to 2015. [2] He is a clinical professor of dermatology at UCLA School of Medicine, Los Angeles. He is a Fellow of the Royal College of Physicians, American Academy of Dermatology and American Society of Laser Medicine and Surgery. [3]
Lowe graduated from University of Liverpool School of Medicine, [4] England, in 1968. In 1975, he was awarded a Research Fellowship at the Scripps Research Institute where he worked with Professor Richard Stoughton, in skin pharmacology and percutaneous absorption. His doctoral MD research thesis escribed mechanisms and control of excessive epidermal cell growth.
In 1975, as a professor of dermatology at University of Wisconsin, he performed research on how ultraviolet light damages the skin and contributes to skin cancers. [5] He was subsequently appointed to Professor of Dermatology [6] at David Geffen School of Medicine at UCLA, Los Angeles, California, United States.
In 1980, he founded the largest psoriasis therapy centre in Southern California, the Dermatology Institute and Skin Care Center, [7] where he also conducted some of the first research studies on vitamin A derivatives for psoriasis, acne and other disfiguring skin diseases. He was appointed to the Medical Advisory Board of the National Psoriasis Foundation in the US.[ citation needed]
In the 1980s, he conducted one of the first clinical research studies in psoriasis a completely new category of drugs for the treatment of psoriasis known as biologic drugs. These were drugs that were capable of targeting immunologic defects in psoriasis; new generations of these biological drugs are now used worldwide as biologic therapy for psoriasis, arthritis and related diseases. [8]
In 1980, he performed research on a category of the first new sunscreens that protected from long wave ultraviolet (or UVA) and UVB. He also confirmed that UVA was responsible for skin aging, skin cancer, unwanted pigmentation and skin sagging and during this research period he also proved the protectiveness of sunscreens against UVA damage in human studies. [9] [10]
In the 1990s, he published research on the use of ultra-pulsed carbon dioxide lasers in dermatology, [11] which were developed and used to reduce skin aging, skin sagging, wrinkling and improve disfiguring scars. [12]
Lowe was the lead investigator in the first placebo control study of Botox for reducing forehead frown lines. At this time neither the dose nor was the safety of Botox was known. Lowe described the how to measure the improvement and using muscle recording electrodes and found the correct muscles to inject Botox. Together with dermatologist Dr Alastair Carruthers, he presented their early studies on the aesthetic use of Botox at the American Academy of Dermatology symposium. [13] He has also shown that Botox injections are an effective way of reducing and controlling the sweating for long periods of time. Pivotal publications on this include a British Medical Journal paper. [14]
Dr Lowe has written over 450 clinical and research papers and 19 books, sits on the editorial board of scientific journals and is a founding editor of the Journal of Cutaneous Laser Therapy. [18] [19]
Books for the general public:
Published medical books in chronological order are:
{{
cite book}}
: CS1 maint: multiple names: authors list (
link)
{{
cite book}}
: CS1 maint: multiple names: authors list (
link)
Nicholas Lowe | |
---|---|
Born | England | July 10, 1944
Education | University of Liverpool |
Occupation | Dermatologist |
Title | Clinical Professor of Dermatology |
Nicholas J Lowe (born 10 July 1944) is an English dermatologist who has published research into skin pharmacology, botulinum toxins, injectable filler and Lasers in cutaneous and cosmetic Surgery. [1]
He was president of the British Cosmetic Dermatology Group from 2013 to 2015. [2] He is a clinical professor of dermatology at UCLA School of Medicine, Los Angeles. He is a Fellow of the Royal College of Physicians, American Academy of Dermatology and American Society of Laser Medicine and Surgery. [3]
Lowe graduated from University of Liverpool School of Medicine, [4] England, in 1968. In 1975, he was awarded a Research Fellowship at the Scripps Research Institute where he worked with Professor Richard Stoughton, in skin pharmacology and percutaneous absorption. His doctoral MD research thesis escribed mechanisms and control of excessive epidermal cell growth.
In 1975, as a professor of dermatology at University of Wisconsin, he performed research on how ultraviolet light damages the skin and contributes to skin cancers. [5] He was subsequently appointed to Professor of Dermatology [6] at David Geffen School of Medicine at UCLA, Los Angeles, California, United States.
In 1980, he founded the largest psoriasis therapy centre in Southern California, the Dermatology Institute and Skin Care Center, [7] where he also conducted some of the first research studies on vitamin A derivatives for psoriasis, acne and other disfiguring skin diseases. He was appointed to the Medical Advisory Board of the National Psoriasis Foundation in the US.[ citation needed]
In the 1980s, he conducted one of the first clinical research studies in psoriasis a completely new category of drugs for the treatment of psoriasis known as biologic drugs. These were drugs that were capable of targeting immunologic defects in psoriasis; new generations of these biological drugs are now used worldwide as biologic therapy for psoriasis, arthritis and related diseases. [8]
In 1980, he performed research on a category of the first new sunscreens that protected from long wave ultraviolet (or UVA) and UVB. He also confirmed that UVA was responsible for skin aging, skin cancer, unwanted pigmentation and skin sagging and during this research period he also proved the protectiveness of sunscreens against UVA damage in human studies. [9] [10]
In the 1990s, he published research on the use of ultra-pulsed carbon dioxide lasers in dermatology, [11] which were developed and used to reduce skin aging, skin sagging, wrinkling and improve disfiguring scars. [12]
Lowe was the lead investigator in the first placebo control study of Botox for reducing forehead frown lines. At this time neither the dose nor was the safety of Botox was known. Lowe described the how to measure the improvement and using muscle recording electrodes and found the correct muscles to inject Botox. Together with dermatologist Dr Alastair Carruthers, he presented their early studies on the aesthetic use of Botox at the American Academy of Dermatology symposium. [13] He has also shown that Botox injections are an effective way of reducing and controlling the sweating for long periods of time. Pivotal publications on this include a British Medical Journal paper. [14]
Dr Lowe has written over 450 clinical and research papers and 19 books, sits on the editorial board of scientific journals and is a founding editor of the Journal of Cutaneous Laser Therapy. [18] [19]
Books for the general public:
Published medical books in chronological order are:
{{
cite book}}
: CS1 maint: multiple names: authors list (
link)
{{
cite book}}
: CS1 maint: multiple names: authors list (
link)